New EU Commissioner John Dalli: Not very concrete on gene technology policy
(15 January 2010) With regard to products of gene
technology, the designated EU Commissioner for Health and Consumer Safety, John Dalli (Malta)
intends to make decisions based on science. However, at a hearing by the
European Parliament he avoided concrete statements on important current topics
of European gene technology policy.
John Dalli, a long-term Minister in Malta, is expected to become a sort of
‘super-Commissioner’ for questions of gene technology. José Manuel Barroso, already
voted in as previous and new President of the Commission, states the wish to
bundle most responsibilities in this field for the future Commissar for Health
and Consumer Safety. Dalli would attain responsibility for the European Food
Safety Authority (EFSA) and the European Medicines Agency (EMEA). Additionally,
he would be charged with the gene technology departments of the environmental
commission.
During the three-hour-long hearing in the European Parliament, Dalli
nonetheless avoided specifics with regard to the gene technology topics that
rank highly on the agenda of the new Commission.
"Science is the basis of all decisions," responded Dalli to a question of the
manner in which he intents to guarantee the safety of genetically modified (GM)
products. He further stated that it is very important that scientific assessment
remain independent.
Dalli also stated his intention regularly to proof the independence of
central approval agencies under his leadership in Europe with regard to food and
medicine.
Dalli also avoided the question of whether Member States in the future will
decide upon the cultivation of GM plants on their own territory. In previous
interviews, Dalli had expressed support for a corresponding suggestion by
Barroso. In the "Political Guidelines" that form the foundation of Barroso’s
second office as President of the Commission, he recommends "in the case of
genetically modified organisms, the adoption of an EU-wide approval system but
simultaneously to leave Member States with the freedom to decide whether they
wish to cultivate genetically modified plants on their territory or not." Last
year, some Member States including the Netherlands and Austria had requested
similar conditions in order to break the political deadlock in European gene
technology policy.
If the EU Parliament approves the new Commission on the 26th of January, the
body may begin work on the 1st of February. It will then make a decision on
cultivation approval for the GM potato known as Amflora.
However, the Parliament can only vote on the approval of the entire
Commission. In the case that individual Commission candidates prove undesirable
for a majority of the Parliament, the assumption of office for the new
Commission may be delayed.
See also on GMO-Compass:
Further information:
|